KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Interest Expenses (2016 - 2025)

Amgen (AMGN) has 17 years of Interest Expenses data on record, last reported at $653.0 million in Q4 2025.

  • For Q4 2025, Interest Expenses fell 12.58% year-over-year to $653.0 million; the TTM value through Dec 2025 reached $2.8 billion, down 12.68%, while the annual FY2025 figure was $2.8 billion, 12.68% down from the prior year.
  • Interest Expenses reached $653.0 million in Q4 2025 per AMGN's latest filing, down from $685.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $824.0 million in Q1 2024 and bottomed at $281.0 million in Q2 2021.
  • Average Interest Expenses over 5 years is $569.4 million, with a median of $669.0 million recorded in 2025.
  • Peak YoY movement for Interest Expenses: decreased 17.63% in 2021, then skyrocketed 129.27% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $335.0 million in 2021, then increased by 23.88% to $415.0 million in 2022, then skyrocketed by 97.83% to $821.0 million in 2023, then fell by 9.01% to $747.0 million in 2024, then fell by 12.58% to $653.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $653.0 million in Q4 2025, $685.0 million in Q3 2025, and $694.0 million in Q2 2025.